A detailed history of Boxer Capital, LLC transactions in Dbv Technologies S.A. stock. As of the latest transaction made, Boxer Capital, LLC holds 250,000 shares of DBVT stock, worth $200,000. This represents 0.01% of its overall portfolio holdings.

Number of Shares
250,000
Previous 500,000 50.0%
Holding current value
$200,000
Previous $375,000 46.67%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.54 - $1.05 $135,000 - $262,500
-250,000 Reduced 50.0%
250,000 $200,000
Q4 2023

Feb 14, 2024

SELL
$0.7 - $1.33 $665,000 - $1.26 Million
-950,000 Reduced 65.52%
500,000 $475,000
Q4 2022

Feb 14, 2023

SELL
$1.16 - $1.8 $794,133 - $1.23 Million
-684,598 Reduced 32.07%
1,450,000 $2.22 Million
Q4 2021

Feb 14, 2022

SELL
$1.39 - $5.58 $7.51 Million - $30.1 Million
-5,400,000 Reduced 71.67%
2,134,598 $3.42 Million
Q3 2020

Nov 16, 2020

BUY
$1.58 - $4.77 $790,000 - $2.39 Million
500,000 Added 7.11%
7,534,598 $13 Million
Q1 2020

May 15, 2020

BUY
$2.33 - $12.98 $1.51 Million - $8.44 Million
650,000 Added 10.18%
7,034,598 $27.6 Million
Q4 2019

Feb 14, 2020

BUY
$6.75 - $11.15 $7.32 Million - $12.1 Million
1,084,598 Added 20.46%
6,384,598 $68.3 Million
Q2 2019

Aug 14, 2019

BUY
$7.58 - $10.0 $8.34 Million - $11 Million
1,100,000 Added 26.19%
5,300,000 $43.6 Million
Q1 2019

May 15, 2019

SELL
$5.81 - $9.37 $1.74 Million - $2.81 Million
-300,000 Reduced 6.67%
4,200,000 $32.4 Million
Q4 2018

Feb 14, 2019

BUY
$5.75 - $21.85 $17.3 Million - $65.6 Million
3,000,000 Added 200.0%
4,500,000 $28.9 Million
Q3 2018

Nov 14, 2018

BUY
$16.81 - $24.58 $7.31 Million - $10.7 Million
435,000 Added 40.85%
1,500,000 $33.7 Million
Q2 2018

Aug 14, 2018

BUY
$18.6 - $24.94 $837,000 - $1.12 Million
45,000 Added 4.41%
1,065,000 $20.5 Million
Q1 2018

May 15, 2018

BUY
$20.86 - $26.6 $21.3 Million - $27.1 Million
1,020,000 New
1,020,000 $23.5 Million

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $150M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.